TAYEDRIA Trademark

Trademark Overview


On Friday, January 22, 2016, a trademark application was filed for TAYEDRIA with the United States Patent and Trademark Office. The USPTO has given the TAYEDRIA trademark a serial number of 79185575. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 15, 2022. This trademark is owned by Novartis AG. The TAYEDRIA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
tayedria

General Information


Serial Number79185575
Word MarkTAYEDRIA
Filing DateFriday, January 22, 2016
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 15, 2022
Registration Number5033968
Registration DateTuesday, September 6, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, September 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, December 20, 2022NOTIFICATION PROCESSED BY IB
Saturday, October 1, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, October 1, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, November 4, 2016NOTIFICATION PROCESSED BY IB
Thursday, October 13, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 13, 2016FINAL DISPOSITION PROCESSED
Thursday, October 6, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, September 6, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, July 28, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 1, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 1, 2016NOTICE OF PUBLICATION
Thursday, May 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 9, 2016ASSIGNED TO EXAMINER
Friday, April 8, 2016APPLICATION FILING RECEIPT MAILED
Monday, April 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 1, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 31, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB